(Q33910630)

30 July 2017

5 references

25 June 2019

6 August 2019

8 September 2019

2 November 2020

6 July 2021

Pharmacogenomics: the genomics of drug response (English)

1 reference

pharmaceutical preparation

30 July 2017

2 references

6 July 2021

1 reference

2 references

6 August 2019

2 references

8 September 2019

1 reference

1 reference

2 November 2020

0 references

March R

1

1 reference

30 July 2017

1 April 2000

6 references

30 July 2017

25 June 2019

6 August 2019

8 September 2019

2 November 2020

6 July 2021

6 references

30 July 2017

25 June 2019

6 August 2019

8 September 2019

2 November 2020

6 July 2021

17

1 reference

30 July 2017

16-21

1 reference

30 July 2017

1

1 reference

Creative Commons Attribution

30 July 2017

5 references

25 June 2019

6 August 2019

8 September 2019

2 November 2020

6 July 2021

0 references

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447033

Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?

28 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2447033

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.

28 July 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Human adrenoceptor polymorphisms: evolving recognition of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Enzymatic Deficiency in Primaquine-Sensitive Erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Concise review: gene expression applied to toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Allelic variants of human calcitonin receptor in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Microarrays and toxicology: the advent of toxicogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Revolution through genomics in investigative and discovery toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Pharmacogenomics. Interview by Clare Thompson

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

… as consortium plans free SNP map of human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0061%28200004%2917%3A1%3C16%3A%3AAID-YEA6%3E3.0.CO%3B2-E

Analysts, firms pour cold water on SNP Consortium

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10797598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/(SICI)1097-0061(200004)17:1<16::AID-YEA6>3.0.CO;2-E

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference

PubMed ID

10797598